Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (3)
  • 2025 (3)
  • 2024 (2)
  • 2023 (3)
  • 2022 (4)
  • 2021 (3)
  • 2020 (1)

Subject

  • Drug Trafficking (231)
  • Synthetic drugs (193)
  • Arrests/Convictions - Major (135)
  • Seizures (Drugs/Property) (78)
  • Guns/Weapons (75)
  • Fake Pills (53)
  • Guilty Plea (43)
  • Major Law Enforcement Operation (40)
  • Prescription Drugs (30)
  • Overdose (26)
  • OCDETF/Task Force (23)
  • Diversion Division (18)
  • Take Back Day (18)
  • Gangs (14)
  • Outreach/Drug Prevention (14)
  • Money Laundering (13)
  • Extraditions (11)
  • Task Forces/Task Force Officers (11)
  • Counterfeit Pills (7)
  • Fentanyl Awareness (7)
  • Prevention/Education - DEA websites GSAD, JTT etc (6)
  • Fentanyl Free America (5)
  • Public and Media Affairs - also see Congressional Affairs (5)
  • Press Conferences (4)
  • Dark Web- Internet Trafficking (3)
  • HIDTA (3)
  • International/Foreign Operations (3)
  • One Pill Can Kill (3)
  • Asset Forfeiture (2)
  • Campaigns (2)
  • Cartel (2)
  • Narcoterrorism (2)
  • Congressional Affairs (1)
  • Critical Incident (1)
  • El Paso Intelligence Center (1)
  • Other (1)
  • Recruitment/Office of Training/Graduations (1)
  • Red Ribbon (1)
  • Scam Calls (1)
  • Terrorism (1)
  • Pharmaceuticals/Pharmacists/Physicians (19)

Drug Name

  • Opioids (4)
  • Oxycodone (3)
  • Benzodiazepines (1)
  • Fentanyl (1)
  • Hydromorphone (1)
  • Morphine (1)

Field Division

  • Atlanta (12)
  • Chicago (19)
  • Dallas (8)
  • El Paso (11)
  • Houston (7)
  • Los Angeles (4)
  • Louisville (7)
  • Miami (16)
  • New England (5)
  • New Jersey (11)
  • New Orleans (4)
  • New York (21)
  • Omaha (3)
  • Philadelphia (1)
  • Phoenix (2)
  • Rocky Mountain (4)
  • San Diego (5)
  • San Francisco (8)
  • Seattle (9)
  • Sede (10)
  • St. Louis (36)
  • Washington, DC (35)
Clear All Results
19 Results - Showing 1 to 10
PRESS RELEASE

United States Files Civil Complaint Against New Mexico Psychologist Alleging Improper Prescribing of Controlled Substances

Note: View the Civil Complaint ALBUQUERQUE – The United States has filed a civil complaint in federal court alleging that a New Mexico psychologist unlawfully prescribed controlled substances without a legitimate medical purpose, in violation of the Controlled Substances Act. In a complaint filed in federal court, the United States...
PRESS RELEASE

Sutter Facilities Agree to Pay $3.2 Million to Resolve Alleged Controlled Substances Act Violations

SACRAMENTO, Calif. — Sutter Medical Center, Sacramento, and Sutter Fairfield Surgery Center have agreed to pay $3.2 million to resolve allegations that they failed to effectively guard against theft and diversion of controlled substances, U.S. Attorney Eric Grant and Drug Enforcement Administration Special Agent in Charge Bob P. Beris announced...
PRESS RELEASE

El Paso Doctor Enters $200,000 Settlement Following State and Federal Fraud Allegations

EL PASO, Texas – Dr. Brian August, located in El Paso, has agreed to pay $200,000 to resolve allegations that he violated the Controlled Substances Act, the False Claims Act, and the Texas Health Care Program Fraud Prevention Act. The allegations involved the issuance of 255 controlled substance prescriptions to...
PRESS RELEASE

Southern New Mexico Medical Spa Operator Settles Allegations of Controlled-Substance Recordkeeping Violations

Note: View the Settlement Agreement ALBUQUERQUE – The United States has reached a civil settlement with Luis Carlos Cordova, operator of Limitless Aesthetics and Healthcare in Santa Teresa, New Mexico, to resolve allegations that he failed to meet federal controlled-substance recordkeeping requirements under the Controlled Substances Act. According to the...
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

SAN FRANCISCO – United States Drug Enforcement Administration (“DEA”) San Francisco Division Special Agent in Charge Bob Beris, DEA New York Division Special Agent in Charge Frank Tarentino, along with our law enforcement partners Homeland Security Investigations (“HSI”) , U.S. Department of Health and Human Services – Office of Inspector...
PRESS RELEASE

DEA Hosts the 29th National Prescription Drug Take Back Day on Saturday, October 25th

SAN FRANCISCO – The Drug Enforcement Administration, in collaboration with nearly 4,000 law enforcement partners across the country, will host the 29th National Prescription Drug Take Back Day this Saturday, October 25, from 10 a.m. to 2 p.m. At nearly 4,000 collection sites throughout the United States, DEA’s National Prescription...
PRESS RELEASE

Madera Pharmacist Sentenced to over 7 Years in Prison for Illegally Trafficking Hundreds of Thousands of Opiate Pills

FRESNO, Calif. — Ifeanyi Vincent Ntukogu, 49, of Fresno, was sentenced today to seven years and three months in prison for illegally distributing oxycodone and hydrocodone. Ntukogu was a pharmacist in Madera who dispensed more than 450,000 oxycodone and hydrocodone pills based on fraudulent prescriptions, all in exchange for cash...
PRESS RELEASE

East Bay Doctor Sentenced to Prison for Distributing Opioids Outside the Scope of Medical Practice

OAKLAND, Calif. – Parto Karimi, a former Bay Area doctor, has been sentenced to one year and one day in federal prison for distributing powerful opioids outside the scope of medical practice, announced United States Attorney Ismail J. Ramsey and Drug Enforcement Administration (DEA), San Francisco Field Division, Special Agent...
PRESS RELEASE

Federal Court Shuts Down San Joaquin County Pharmacy and Orders $1 Million in Civil Penalties

SACRAMENTO, Calif. — Nor-Cal Pharmacies Inc., doing business as Lockeford Drug, and pharmacist/owner Lawrence Howen have agreed to pay $1 million in penalties to resolve allegations of violations of the Controlled Substances Act, U.S. Attorney Phillip A. Talbert and Drug Enforcement Administration Special Agent in Charge Brian M. Clark announced...
PRESS RELEASE

Drug Enforcement Administration Announces Fall Take Back Day

El Paso, Texas – On Saturday October 28, from 10 a.m. to 2 p.m., the Drug Enforcement Administration and various local agencies will host DEA’s National Prescription Drug Take Back Day at locations across the country. DEA and its partners will collect tablets, capsules, patches, and other solid forms of...

Paginación

  • Current page 1
  • Page 2
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster